MÔ TẢ MỘT SỐ ĐẶC ĐIỂM NHIỄM LIÊN CẦU KHUẨN NHÓM B VÀ KẾT QUẢ ĐIỀU TRỊ DỰ PHÒNG BẰNG KHÁNG SINH Ở PHỤ NỮ CÓ THAI TỪ 35 -37 TUẦN TẠI BỆNH VIỆN SẢN NHI NGHỆ AN 2019

Abstract

Objectives: The study aims to describe some characteristics of GBS and results of preventive treatment
with antibiotics in 35-37 week pregnant women at Nghe An Obstetrics and Pediatrics Hospital from
2018 to 2019.
Study subjects and methods: The descriptive method combined with analysis and experimental
study in laboratory was employed. Study subjects included pregnant women of 35 - 37 weeks. The
pregnant women had clinical examinations, and were interviewed. Vaginal discharge was taken
for culture and identification of Group B Streptococcus and β hemolytic S-shaped colonies on
blood agar.
Results: The prevalence of Group B streptococcus via clinical examinations was 9.2%. 100% of
the pregnant women used prophylactic antibiotics. 68.5% were injected one shot of antibiotics.
Cephalothin injection was safe for the mothers with 100.0% of the women having no side effects.
Preventive treatment results for the newborn babies after 48 hours of birth were very good,
specifically, no infants had skin inflammation, umbilical cord infection, or pneumonia; only one
infant was infected with E.coli accounting for 1.8%.
Conclusions and recommendations: There is a need to screen and diagnose of group B streptococcus
and do early treatment for pregnant women at the 35th to 37th week to prevent infection for mothers
and newborn babies.